Numinus Wellness (FRA:LR23) Momentum Rank : 0 (As of Jun. 05, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Numinus Wellness Momentum Rank?

Numinus Wellness has the Momentum Rank of 0.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Numinus Wellness Momentum Rank Related Terms

Thank you for viewing the detailed overview of Numinus Wellness's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Numinus Wellness (FRA:LR23) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Numinus Wellness Inc (FRA:LR23) » Definitions » Momentum Rank

Comparable Companies

Traded in Other Exchanges

NUMIF:USA NUMI:Canada

Address

801 - 33 Water Street, Vancouver, BC, CAN, V6B 1R4

Website

https://www.numinus.ca

Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.

Numinus Wellness (FRA:LR23) Headlines

No Headlines